The ARKK ETF diversified its biotech holdings with the addition of 61,866 shares of GUARDANT HEALTH INC (NASDAQ: GH) at a value of $3 million and 75,316 shares of VERACYTE INC (NASDAQ: VCYT) worth ...

Here’s why investors with a high risk appetite can consider gaining exposure to disruptive exchange-traded funds ETFs such as ...

This is the ideal market environment for Cathie Wood. Stocks are rallying, and the founder, CEO, and chief investment officer ...

Cathie Wood and her flagship ARK Innovation ETFARKK have struggled in recent years. ARKK dived in 2021-2022 and then lagged or barely kept pace with the S&P 500 index in the next two years as Cathie ...

Cathie Wood’s ARK Invest made its first Circle stock sale just 11 days after the public launch, selling 342,658 CRCL shares ...

Recursion Pharmaceuticals ( RXRX 2.13%) is not the most famous artificial intelligence (AI) stock on the market, but the ...

Warren Buffett, Cathie Wood, and Bill Ackman are three powerhouse investors who each have a different approach to investing.

Wood buys Tesla again as investment firms spend more money due to business-friendly policies. Remains bullish on Tesla and ...

Ark Invest, in collaboration with consulting firm Mach33, forecast that SpaceX could reach an enterprise value of $2.5 ...

A solid sale of 30-year Treasuries reduced fears that spiraling deficits are causing investors to shun the maturity, with ...

Corporate America is regaining its appetite for risk as expectations build around Donald Trump’s push for deregulation and tax cuts, according to ARK Investment Management founder Cathie Wood.

But while everyday people grapple with the reality of this change, experts in the space continue to forecast what's to come — ...